The present invention relates to the use of at least one antibody and/or oneinhibitor for inhibiting factor XII and preventing the formation and/or thestabilization of threedimensional thrombi. It also relates to a pharmaceuticalformulation and the use of factor XII as an anti-thrombotic target.